Europe - FRA:CVS - US1266501006 - Common Stock
The current stock price of CVS.DE is 68.51 EUR. In the past month the price increased by 2.79%. In the past year, price increased by 29.05%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| FRE.DE | FRESENIUS SE & CO KGAA | 17.14 | 26.83B | ||
| FME.DE | FRESENIUS MEDICAL CARE AG | 12.86 | 24.29B | ||
| V3V.DE | FAMICORD AG | 38.57 | 95.26M | ||
| HI.MI | HEALTH ITALIA SPA | 20.33 | 54.15M |
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. The company is headquartered in Woonsocket, Rhode Island and currently employs 300,000 full-time employees. The firm's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, PDPs and Medicaid health care management services. The Health Services segment provides a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells an assortment of health and wellness products and general merchandise.
CVS HEALTH CORP
One Cvs Dr.
Woonsocket RHODE ISLAND US
Employees: 259500
Phone: 14017651500
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. The company is headquartered in Woonsocket, Rhode Island and currently employs 300,000 full-time employees. The firm's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, PDPs and Medicaid health care management services. The Health Services segment provides a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells an assortment of health and wellness products and general merchandise.
The current stock price of CVS.DE is 68.51 EUR. The price increased by 0.1% in the last trading session.
CVS HEALTH CORP (CVS.DE) has a dividend yield of 3.47%. The yearly dividend amount is currently 2.29.
CVS.DE has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
33 analysts have analysed CVS.DE and the average price target is 74.21 EUR. This implies a price increase of 8.32% is expected in the next year compared to the current price of 68.51.
CVS HEALTH CORP (CVS.DE) has a market capitalization of 86.89B EUR. This makes CVS.DE a Large Cap stock.
You can find the ownership structure of CVS HEALTH CORP (CVS.DE) on the Ownership tab.
ChartMill assigns a technical rating of 10 / 10 to CVS.DE. When comparing the yearly performance of all stocks, CVS.DE is one of the better performing stocks in the market, outperforming 89.19% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to CVS.DE. CVS.DE has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months CVS.DE reported a non-GAAP Earnings per Share(EPS) of 5.94. The EPS increased by 7.87% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.12% | ||
| ROA | 0.18% | ||
| ROE | 0.64% | ||
| Debt/Equity | 0.85 |
33 analysts have analysed CVS.DE and the average price target is 74.21 EUR. This implies a price increase of 8.32% is expected in the next year compared to the current price of 68.51.
For the next year, analysts expect an EPS growth of 18.7% and a revenue growth 6.16% for CVS.DE